We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
-13.76%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$46.3M
Cap. Flow
-$6.65M
Cap. Flow %
-3.11%
Top 10 Hldgs %
34.52%
Holding
328
New
4
Increased
14
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.01M
2
CARR icon
Carrier Global
CARR
+$374K
3
ACGL icon
Arch Capital
ACGL
+$201K
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$131K
5
DIS icon
Walt Disney
DIS
+$123K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$1.71M
2
NVDA icon
NVIDIA
NVDA
+$849K
3
AAPL icon
Apple
AAPL
+$804K
4
PACB icon
Pacific Biosciences
PACB
+$803K
5
ABT icon
Abbott
ABT
+$758K

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 24.61%
3 Industrials 12.39%
4 Consumer Staples 9.1%
5 Communication Services 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSYS icon
276
Stratasys
SSYS
$760M
$7K ﹤0.01%
360
– –
ARRY icon
277
Array Technologies
ARRY
$809M
$6K ﹤0.01%
590
– –
DDD icon
278
3D Systems Corp
DDD
$588M
$6K ﹤0.01%
580
– –
HP icon
279
Helmerich & Payne
HP
$3.7B
$6K ﹤0.01%
130
– –
PTCT icon
280
PTC Therapeutics
PTCT
$5.91B
$6K ﹤0.01%
145
– –
SRPT icon
281
Sarepta Therapeutics
SRPT
$1.77B
$6K ﹤0.01%
85
– –
FANG icon
282
Diamondback Energy
FANG
$53.1B
$5K ﹤0.01%
41
– –
MELI icon
283
Mercado Libre
MELI
$92.8B
$5K ﹤0.01%
8
– –
NOK icon
284
Nokia
NOK
$52.6B
$5K ﹤0.01%
1,000
– –
RARE icon
285
Ultragenyx Pharmaceutical
RARE
$2.55B
$5K ﹤0.01%
90
– –
TVRD
286
Tvardi Therapeutics
TVRD
$23.1M
$5K ﹤0.01%
16
– –
AERI
287
DELISTED
Aerie Pharmaceuticals
AERI
$5K ﹤0.01%
710
– –
SAGE
288
DELISTED
Sage Therapeutics
SAGE
$4K ﹤0.01%
130
– –
SSP icon
289
E.W. Scripps
SSP
$270M
$4K ﹤0.01%
300
– –
UFI icon
290
UNIFI
UFI
$128M
$4K ﹤0.01%
310
– –
IMGN
291
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
980
– –
ATRA icon
292
Atara Biotherapeutics
ATRA
$74.3M
$3K ﹤0.01%
14
– –
CARS icon
293
Cars.com
CARS
$656M
$3K ﹤0.01%
316
– –
CCL icon
294
Carnival Corporation Ltd
CCL
$39.4B
$3K ﹤0.01%
400
– –
LXRX icon
295
Lexicon Pharmaceuticals
LXRX
$1.05B
$3K ﹤0.01%
1,650
– –
PRTA icon
296
Prothena Corp
PRTA
$449M
$3K ﹤0.01%
110
– –
VTR icon
297
Ventas
VTR
$47.3B
$3K ﹤0.01%
50
– –
TPC
298
Tutor Perini Cor
TPC
$5.03B
$3K ﹤0.01%
300
– –
EGIO
299
DELISTED
Edgio, Inc. Common Stock
EGIO
$3K ﹤0.01%
33
– –
AMRS
300
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
1,590
– –
9 10 11
12
13

Similar funds

EC
Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
SAMT
Select Asset Management & Trust Mechanicsburg, Pennsylvania $320M AUM 18.83% 1-Year Est. Return
FPL
Fortress Private Ledger Raleigh, North Carolina $320M AUM 45.16% 1-Year Est. Return
SGF
Stephens Greth Foundation Dallas, Texas $320M AUM
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return

Laurie J. Hall Trustee's Q2 2022 Portfolio in Review

As of Q2 2022, Laurie J. Hall Trustee held 328 positions worth $214M, down 18% from $260M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Laurie J. Hall Trustee withdrew a net $6.65M in Q2 2022, closing 7 positions and reducing 70 holdings. Its most notable exit was Pacific Biosciences, an estimated $803K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Laurie J. Hall Trustee opened a new position in Arch Capital worth $197K.

  • Laurie J. Hall Trustee's largest Q2 2022 buy was Arch Capital: 4,326 shares worth $197K.
  • Laurie J. Hall Trustee added most to Medtronic in Q2 2022, an estimated $2.01M increase.
  • Laurie J. Hall Trustee's biggest Q2 2022 reduction was Unilever, cutting an estimated $1.71M.
  • Laurie J. Hall Trustee fully exited Pacific Biosciences in Q2 2022, selling an estimated $803K.
  • Laurie J. Hall Trustee's ten largest holdings make up 35% of its $214M portfolio in Q2 2022.
  • Laurie J. Hall Trustee opened 4 new positions and closed 7 in Q2 2022.
  • Laurie J. Hall Trustee's portfolio value fell 18% quarter-over-quarter to $214M.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2022, filed 6 Jul 2022.